Charles River Laboratories International, Inc. (CRL)
284.57
+2.23
(+0.79%)
USD |
NYSE |
Sep 02, 11:50
Charles River Laboratories International Cash from Operations (TTM) : 582.15M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 582.15M |
| March 31, 2026 | 607.03M |
| December 31, 2025 | 737.65M |
| September 30, 2025 | 749.49M |
| June 30, 2025 | 787.45M |
| March 31, 2025 | 776.39M |
| December 31, 2024 | 734.58M |
| September 30, 2024 | 796.16M |
| June 30, 2024 | 749.82M |
| March 31, 2024 | 704.40M |
| December 31, 2023 | 683.90M |
| September 30, 2023 | 697.71M |
| June 30, 2023 | 625.04M |
| March 31, 2023 | 626.39M |
| December 31, 2022 | 619.64M |
| September 30, 2022 | 614.14M |
| June 30, 2022 | 656.08M |
| March 31, 2022 | 693.20M |
| December 31, 2021 | 760.80M |
| September 30, 2021 | 669.92M |
| June 30, 2021 | 672.50M |
| March 31, 2021 | 648.21M |
| December 31, 2020 | 546.58M |
| September 30, 2020 | 588.87M |
| June 30, 2020 | 567.42M |
| Date | Value |
|---|---|
| March 31, 2020 | 534.67M |
| December 31, 2019 | 480.94M |
| September 30, 2019 | 440.23M |
| June 30, 2019 | 401.63M |
| March 31, 2019 | 395.95M |
| December 31, 2018 | 441.14M |
| September 30, 2018 | 425.40M |
| June 30, 2018 | 367.64M |
| March 31, 2018 | 344.10M |
| December 31, 2017 | 318.07M |
| September 30, 2017 | 308.09M |
| June 30, 2017 | 318.21M |
| March 31, 2017 | 295.86M |
| December 31, 2016 | 300.38M |
| September 30, 2016 | 288.46M |
| June 30, 2016 | 307.14M |
| March 31, 2016 | 315.52M |
| December 31, 2015 | 288.23M |
| September 30, 2015 | 285.74M |
| June 30, 2015 | 264.30M |
| March 31, 2015 | 234.92M |
| December 31, 2014 | 252.13M |
| September 30, 2014 | 214.78M |
| June 30, 2014 | 215.54M |
| March 31, 2014 | 207.53M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| IQVIA Holdings, Inc. | 2.819B |
| Medpace Holdings, Inc. | 752.66M |
| Fortrea Holdings, Inc. | 227.80M |
| Avantor, Inc. | 597.00M |
| Champions Oncology, Inc. | -4.472M |